{"title":"EHA指南对血小板减少的癌症患者的抗血栓治疗管理","authors":"Anna Falanga, Hugo Ten Cate, Bianca Rocca","doi":"10.4081/btvb.2023.60","DOIUrl":null,"url":null,"abstract":"With ageing of the population, both the risks of cardiovascular disease (CVD) and cancer are increasing worldwide, and the risk factors (e.g. obesity, diabetes) are often shared between the two conditions. Thus, more subjects will also develop the two illnesses concurrently [...].","PeriodicalId":486412,"journal":{"name":"Bleeding Thrombosis and Vascular Biology","volume":"9 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"EHA guidelines on management of antithrombotic treatments in thrombocytopenic patients with cancer\",\"authors\":\"Anna Falanga, Hugo Ten Cate, Bianca Rocca\",\"doi\":\"10.4081/btvb.2023.60\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"With ageing of the population, both the risks of cardiovascular disease (CVD) and cancer are increasing worldwide, and the risk factors (e.g. obesity, diabetes) are often shared between the two conditions. Thus, more subjects will also develop the two illnesses concurrently [...].\",\"PeriodicalId\":486412,\"journal\":{\"name\":\"Bleeding Thrombosis and Vascular Biology\",\"volume\":\"9 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bleeding Thrombosis and Vascular Biology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4081/btvb.2023.60\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bleeding Thrombosis and Vascular Biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4081/btvb.2023.60","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
EHA guidelines on management of antithrombotic treatments in thrombocytopenic patients with cancer
With ageing of the population, both the risks of cardiovascular disease (CVD) and cancer are increasing worldwide, and the risk factors (e.g. obesity, diabetes) are often shared between the two conditions. Thus, more subjects will also develop the two illnesses concurrently [...].
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
